Science Explorer Back to mapMap
Discussion
Company · Huddinge · Sweden

Medivir (Sweden)

medivir.seROR OpenAlex
World rank, all time
#34,772
of 34,923
Rank in Sweden
#258
of 259
Research works
138
▼ 66% vs 2018-21
Citations
3.8k
27.6 per fractional work
Top-10% rate
7.0%
all institutions 10.0%
vs its own fields
0.99×
1.00× is exactly expected
Open access
36%
world 40%
International
26%
world 18%
Medivir (Sweden)

Which fields of science does Medivir (Sweden) work in?

In all years, 49% of research at Medivir (Sweden) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (49%), Biochemistry, Genetics and Molecular Biology (21%), Chemistry (12%). It does 2.0× the world's share of Life Sciences.

Health Sciences: 68 fractional works · 49.0% of its workMedicine: 68 fractional works · 49.0% of its workInfectious Diseases: 18 fractional works · 13.3% of its workEpidemiology: 12 fractional works · 8.4% of its workHepatology: 9 fractional works · 6.5% of its workOncology: 5 fractional works · 3.6% of its workRheumatology: 4 fractional works · 3.1% of its workPharmacology: 3 fractional works · 2.0% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 1.9% of its workPhysiology: 2 fractional works · 1.5% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 1.3% of its workGenetics: 1 fractional works · 1.0% of its workImmunology and Allergy: 1 fractional works · 0.7% of its workDermatology: 1 fractional works · 0.7% of its workOrthopedics and Sports Medicine: 1 fractional works · 0.7% of its workSurgery: 1 fractional works · 0.6% of its workHematology: 1 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.5% of its workEmergency Medicine: 1 fractional works · 0.5% of its workPulmonary and Respiratory Medicine: 1 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.5% of its workLife Sciences: 45 fractional works · 32.5% of its workBiochemistry, Genetics and Molecular Biology: 29 fractional works · 20.6% of its workMolecular Biology: 21 fractional works · 15.2% of its workCancer Research: 3 fractional works · 2.2% of its workBiotechnology: 1 fractional works · 1.1% of its workPhysiology: 1 fractional works · 0.6% of its workBiochemistry: 1 fractional works · 0.6% of its workGenetics: 1 fractional works · 0.6% of its workCell Biology: 1 fractional works · 0.4% of its workImmunology and Microbiology: 12 fractional works · 8.7% of its workVirology: 10 fractional works · 7.0% of its workImmunology: 2 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 1.8% of its workPharmacology: 2 fractional works · 1.3% of its workToxicology: 0 fractional works · 0.3% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.5% of its workAgricultural and Biological Sciences: 1 fractional works · 0.6% of its workFood Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 25 fractional works · 18.3% of its workChemistry: 17 fractional works · 12.0% of its workOrganic Chemistry: 14 fractional works · 9.9% of its workSpectroscopy: 2 fractional works · 1.2% of its workInorganic Chemistry: 1 fractional works · 0.6% of its workAnalytical Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 6 fractional works · 4.0% of its workComputational Theory and Mathematics: 5 fractional works · 3.7% of its workComputer Networks and Communications: 0 fractional works · 0.2% of its workEngineering: 2 fractional works · 1.2% of its workBiomedical Engineering: 1 fractional works · 0.8% of its workComputational Mechanics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 1 fractional works · 0.6% of its workMaterials Chemistry: 1 fractional works · 0.6% of its workMathematics: 0 fractional works · 0.4% of its workStatistics and Probability: 0 fractional works · 0.4% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.2% of its workClinical Psychology: 0 fractional works · 0.2% of its workALL ITS WORKMedivir (Sweden)138fractional works, all years
Life Sciences33%Physical Sciences18%Health Sciences49%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine6849.0%
    1. Biochemistry, Genetics and Molecular Biology2920.6%
    2. Immunology and Microbiology128.7%
    3. Pharmacology, Toxicology and Pharmaceutics31.8%
    4. Neuroscience10.8%
    5. Agricultural and Biological Sciences10.6%
    1. Chemistry1712.0%
    2. Computer Science64.0%
    3. Engineering21.2%
    4. Materials Science10.6%
    5. Mathematics00.4%
    6. Physics and Astronomy00.1%
    1. Psychology00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.34× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.56× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.15× its world share, 0 worksImmunology and Micro…Engineering: 1.30× its world share, 1 worksEngineeringPhysics and Astronomy: 1.46× its world share, 0 worksPhysics and AstronomyMedicine: 1.73× its world share, 2 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.6×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology7.56×2 works
  2. Immunology and Microbiology2.15×0 works
  3. Medicine1.73×2 works
  4. Physics and Astronomy1.46×0 works
  5. Engineering1.30×1 works
  6. Agricultural and Biological Sciences0.34×0 works

Who are the top researchers at Medivir (Sweden)?

Ranked on the quality score, Paul Targett‐Adams, Herman de Kock and Michael Edlund lead among researchers whose main affiliation is Medivir (Sweden).

  1. 1 Paul Targett‐Adams Sweden · #562,861 worldwide 3k citations · 47 works
  2. 2 Herman de Kock Sweden · #1,522,447 worldwide 1.4k citations · 32 works
  3. 3 Michael Edlund Sweden · #1,817,967 worldwide 1k citations · 20 works
  4. 4 Kenneth Simmen Sweden · #1,948,928 worldwide 2.3k citations · 53 works
  5. 5 Vera Baraznenok Sweden · #2,793,780 worldwide 1.1k citations · 25 works
  6. 6 Helen Kylefjord Sweden · #2,843,749 worldwide 734 citations · 15 works
  7. 7 Tse‐I Lin Sweden · #2,891,624 worldwide 1.4k citations · 62 works
  8. 8 Nils Gunnar Johansson Sweden · #2,907,992 worldwide 3.2k citations · 103 works
  9. 9 Anders Eneroth Sweden · #2,978,720 worldwide 374 citations · 20 works
  10. 10 Biljana Rizoska Sweden · #3,019,323 worldwide 398 citations · 16 works
All ranked researchers at Medivir (Sweden)

What are the most cited papers from Medivir (Sweden)?

The most cited paper from Medivir (Sweden) is "MAIT cells are activated during human viral infections" (Bonnie van Wilgenburg et al., 2016), with 532 citations. Next come "Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs" (238) and "Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor" (217).

Most cited papers
#PaperReleasedCitations
1 MAIT cells are activated during human viral infections Bonnie van Wilgenburg et al. · Nature Communications Open access 23 Jun 2016 532
2 Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs Staffan Eriksson, Borys Kierdaszuk, Birgitte Munch‐Petersen et al. · Biochemical and Biophysical Research Communications Apr 1991 238
3 Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor Åsa Rosenquist, Bertil Samuelsson, Per-Ola Johansson et al. · Journal of Medicinal Chemistry 21 Jan 2014 217
4 In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435 Oliver Lenz, Thierry Verbinnen, Tse‐I Lin et al. · Antimicrobial Agents and Chemotherapy Open access 23 Feb 2010 211
5 Cathepsin S Causes Inflammatory Pain via Biased Agonism of PAR2 and TRPV4 Peishen Zhao, TinaMarie Lieu, Nicholas Barlow et al. · Journal of Biological Chemistry Open access 13 Aug 2014 191
All 59 most cited papers, with filters and sorting

Which keywords describe research at Medivir (Sweden)?

By fractional works in all years, weighted toward what it does more of than the world: Antiretroviral Therapy, Immune Response, HIV Infection, Drug Resistance, Hepatotoxicity, Integrase Inhibitors, Nucleoside Analogues and Antiviral Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Antiretroviral Therapy30▲ 93×5 topics
  2. Immune Response26▲ 30×10 topics
  3. HIV Infection18▲ 103×2 topics
  4. Drug Resistance17▲ 40×5 topics
  5. Hepatotoxicity17▲ 167×2 topics
  6. Integrase Inhibitors17▲ 294×1 topic
  7. Nucleoside Analogues17▲ 294×1 topic
  8. Epidemiology16▲ 2.9×25 topics
  9. Antiviral Therapy16▲ 74×3 topics
  10. Liver Disease14▲ 73×3 topics
  11. Treatment12▲ 6.6×13 topics
  12. Vaccine12▲ 21×7 topics
  13. HIV11▲ 69×3 topics
  14. Drug Discovery11▲ 20×5 topics
  15. Inflammation11▲ 3.3×23 topics
  16. Genetic Variation10▲ 24×2 topics
  17. Antibodies10▲ 79×2 topics
  18. Immune Activation10▲ 76×2 topics
  19. AIDS10▲ 132×1 topic
  20. neurocognitive disorders10▲ 132×1 topic
  21. Hepatitis C Virus9▲ 121×1 topic
  22. Ribavirin9▲ 121×1 topic
  23. Medicinal Chemistry7▲ 14×6 topics
  24. Molecular Docking7▲ 36×4 topics
  25. Pharmacokinetics7▲ 18×3 topics
  26. Global Burden6▲ 8.7×3 topics
  27. Hepatocellular Carcinoma6▲ 22×3 topics
  28. Click Chemistry6▲ 52×1 topic
  29. Copper-Catalyzed Cycloaddition6▲ 125×1 topic
  30. Enzyme Regulation5▲ 78×2 topics
  31. Drug Target Identification5▲ 53×1 topic
  32. Nucleotide Metabolism5▲ 106×1 topic
  33. Purine Biosynthesis5▲ 106×1 topic
  34. Virtual Screening5▲ 53×1 topic
  35. Chronic Hepatitis B5▲ 71×1 topic
  36. Hepatitis B Virus5▲ 71×1 topic
  37. Matrix Metalloproteinases4▲ 18×2 topics
  38. Foldamers4▲ 33×1 topic
  39. Peptide Synthesis4▲ 33×1 topic
  40. Mesenchymal Stem Cells3▲ 20×2 topics

Which research topics does Medivir (Sweden) publish most on?

By volume in 2022-now: Epigenetics and DNA Methylation, Cancer Research and Treatments, Adenosine and Purinergic Signaling and Surgical Simulation and Training.

Epigenetics and DNA Methylation: 1 fractional worksCancer Research and Treatments: 1 fractional worksAdenosine and Purinergic Signaling: 0 fractional worksSurgical Simulation and Training: 0 fractional worksBladder and Urothelial Cancer Treatments: 0 fractional works3D Shape Modeling and Analysis: 0 fractional worksAnatomy and Medical Tech…0Anatomy and Medical Technology: 0 fractional worksOsteoarthritis Treatment and Mechanisms: 0 fractional worksNanowire Synthesis and Applications: 0 fractional worksThin-Film Transistor Technologies: 0 fractional works
Molecular BiologyBiotechnologyPhysiologySurgery4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Epigenetics and DNA Methylation Molecular Biology 1 works
  2. 2 Cancer Research and Treatments Biotechnology 1 works
  3. 3 Adenosine and Purinergic Signaling Physiology 0 works
  4. 4 Surgical Simulation and Training Surgery 0 works
  5. 5 Bladder and Urothelial Cancer Treatments Surgery 0 works
  6. 6 3D Shape Modeling and Analysis Computational Mechanics 0 works
  7. 7 Anatomy and Medical Technology Biomedical Engineering 0 works
  8. 8 Osteoarthritis Treatment and Mechanisms Rheumatology 0 works
  9. 9 Nanowire Synthesis and Applications Biomedical Engineering 0 works
  10. 10 Thin-Film Transistor Technologies Electrical and Electronic Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.3%not open63.7%

World: 40% of research is openly available.

with international co-authors26.4%domestic only73.6%

World: 18% is written across borders.

How has Medivir (Sweden)'s research output changed?

Output in 2022-2025 was 66% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Medivir (Sweden) as a percentage of every work published that year, 0.000012% in 2024.

still counting0.00020%0.00040%0.00060%Medivir (Sweden)0.0000066% in 20251990200020102020

Fractional works of Medivir (Sweden) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Huddinge

All research institutions in Huddinge

Share Medivir (Sweden)'s ranking

Medivir (Sweden) on Science Explorer

A card with Medivir (Sweden)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Medivir (Sweden). Posts are plain text and can be reported.